• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:罗伟华,韦瑛.复方夏天无片配合穴位封闭治疗坐骨神经炎的临床观察[J].中国现代应用药学,2012,29(4):370-372.
LUO Weihua, WEI Ying.Clinical Observation of Compound Rhizoma Corydalis Decumbentis Tablets Combined with Point Block on the Treatment of Sciatic Nerve Inflammation[J].Chin J Mod Appl Pharm(中国现代应用药学),2012,29(4):370-372.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2811次   下载 3033 本文二维码信息
码上扫一扫!
分享到: 微信 更多
复方夏天无片配合穴位封闭治疗坐骨神经炎的临床观察
罗伟华,韦瑛
广西合山市人民医院,a.药剂科,b.骨外科,广西 合山 546508
摘要:
目的 观察复方夏天无片配合穴位封闭治疗坐骨神经炎的疗效。方法 将60例患者随机分为观察组30例和对照组30例,观察组用复方夏天无片口服,每日3次,每次2片,连续使用2周,并配合常规穴位封闭及口服消炎痛、维生素B1治疗;对照组予以常规穴位封闭及口服消炎痛、维生素B1治疗。结果 观察组临床有效率为96.67%,高于对照组的73.33%,差异有统计学意义(P<0.05)。结论 复方夏天无片治疗坐骨神经炎效果好,不良反应少,是治疗坐骨神经炎的理想药物,值得临床推广应用。
关键词:  复方夏天无片  坐骨神经炎  不良反应  疗效
DOI:
分类号:
基金项目:
Clinical Observation of Compound Rhizoma Corydalis Decumbentis Tablets Combined with Point Block on the Treatment of Sciatic Nerve Inflammation
LUO Weihua, WEI Ying
Heshan People’s Hospital, a.Department of Pharmacy, b.Department of Orthopedics, Heshan 546508, China
Abstract:
OBJECTIVE To observe the clinical efficacy of Compound Rhizoma Corydalis Decumbentis tablets combined with point block on the treatment of the sciatic nerve inflammation. METHODS Sixty patients were randomly divided into the observation group (30 cases) and the control group (30 cases). The control group was treated with point block, oral indomethacin, vitamin B1. The observation group was treated with Compound Rhizoma Corydalis Decumbentis tablets (2 tablets), 3 times a day, continuously for 2 weeks, on the basis of the control group. RESULTS The clinical effective rate of the observation group was 96.67%, and it was 73.33% in the control group, the difference was significant (P<0.05). CONCLUSION Compound Rhizoma Corydalis Decumbentis tablets to treat the sciatic nerve inflammation is safe and effective, it is an ideal drug, and is worthy of clinical application.
Key words:  Compound Rhizoma Corydalis Decumbentis tablets  sciatic nerve inflammation  adverse reactions  clinical efficacy
扫一扫关注本刊微信